Thermo Fisher Scientific Inc.

TMO • Medical - Diagnostics & Research

$687.37

▲ +7.99 (+1.18%)

Precio actual

ResultadosÚltimo reporte: 28 mar 2026

PERFIL FAVORABLEAtractivaConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Alta calidad del negocio, con crecimiento y flujo de caja que respaldan el caso. La valoración todavía importa, pero el historial de ratios es favorable.

Capitalización

$256.39B

Crecimiento

8.0%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Márgenes estables o en mejora · 15.1%Flujo de caja libre positivo · 16.74Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.76Liquidez saludable · 1.89

Datos financieros hasta: 28 mar 2026, 12:00 a.m. UTCÚltima actualización de earnings: 23 abr 2026, 12:00 a.m. UTCÚltima actualización del perfil: 5 ago 2026, 2:27 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$687.37

Change1.18%

Shares Out373.00M

Market Cap$256.39B

Enterprise Value$296.29B

52W Range403.36 - 643.99

Beta0.87

P/E37.38

P/S5.67

P/B4.94

P/FCF37.99

EV/Sales6.56

Price$687.37

Change1.18%

Shares Out373.00M

Market Cap$256.39B

Enterprise Value$296.29B

52W Range403.36 - 643.99

Beta0.87

P/E37.38

P/S5.67

P/B4.94

P/FCF37.99

EV/Sales6.56

EV/EBITDA26.55

EV/FCF43.91

Earnings Yield2.68%

FCF Yield2.63%

Dividend Yield0.25%

Gross Margin37.66%

Oper. Margin18.20%

Profit Margin15.12%

Debt/Eq0.76

Current Ratio1.89

Quick Ratio1.53

Revenue 5Y8.01%

Target$664.79

Target Upside-3.28%

Target Median$685.00

Target Range520.00 - 750.00

Volume2.42M

Avg Volume2.30M

EPS Surprise0.19

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

76/100

Fortaleza financiera

Deuda, caja, estabilidad

82/100

Potencial de crecimiento

Ingresos y expansión

44/100

Atractivo del precio

Barata o cara hoy

49/100

Por qué este puntaje▼

Márgenes estables o en mejora · 15.1%Flujo de caja libre positivo · 16.74Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.76Liquidez saludable · 1.89

Analyst view

Analyst sentiment and price target

TMO

Analyst sentiment

Based on 43 analyst votes · 2026-10-20

92/100

Bullish

Hold

Bearish

Precio objetivo

2026-07-01

Bajo

$490.00

Promedio

$592.45

Mediana

$615.00

Alto

$683.00

Resumen de la compañía

IPO: 3/17/1980

Industria: Medical - Diagnostics & Research

P/B i: 4.94

Deuda / Patrimonio i: 0.76

Margen operativo: 18.20%

Margen neto: 15.12%

ROE i: -

ROIC: -

Salud financiera

Puntaje16 / 20

Deuda / Patrimonio: 0.76

Ratio corriente: 1.89

Ratio rápido: 1.53

Estado: Strong

Transacciones internas

Actividad reciente de ejecutivos e insiders

JOHNSON JENNIFER M

Transacción: 06/27/2026

COMPRA

Cambio

—

Precio

Not reported

Presentación

06/30/2026

Tipo

COMPRA

Lynch Karen S

Transacción: 06/27/2026

COMPRA

Cambio

—

Precio

Not reported

Presentación

06/30/2026

Tipo

COMPRA

WEISLER DION J

Transacción: 06/27/2026

COMPRA

Cambio

—

Precio

Not reported

Presentación

06/30/2026

Tipo

COMPRA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
JOHNSON JENNIFER M	COMPRA	—	Not reported	06/27/2026	06/30/2026
Lynch Karen S	COMPRA	—	Not reported	06/27/2026	06/30/2026
WEISLER DION J	COMPRA	—	Not reported	06/27/2026	06/30/2026
Keith R. Alexandra	COMPRA	—	Not reported	06/27/2026	06/30/2026
SPERLING SCOTT M	COMPRA	—	Not reported	06/27/2026	06/30/2026
Chai Nelson	COMPRA	+499	Not reported	05/20/2026	05/22/2026
CHANDY RUBY R	COMPRA	+499	Not reported	05/20/2026	05/22/2026
HARRIS C MARTIN	COMPRA	+499	Not reported	05/20/2026	05/22/2026
Jacks Tyler	COMPRA	+499	Not reported	05/20/2026	05/22/2026
JOHNSON JENNIFER M	COMPRA	+499	Not reported	05/20/2026	05/22/2026
Keith R. Alexandra	COMPRA	+499	Not reported	05/20/2026	05/22/2026
Lynch Karen S	COMPRA	+499	Not reported	05/20/2026	05/22/2026
Spar Debora L	COMPRA	+499	Not reported	05/20/2026	05/22/2026
SPERLING SCOTT M	COMPRA	+499	Not reported	05/20/2026	05/22/2026
WEISLER DION J	VENTA	—	$451.79	05/20/2026	05/22/2026
Pettiti Gianluca	VENTA	-400	$462.66	04/27/2026	04/29/2026
WEISLER DION J	COMPRA	—	Not reported	03/28/2026	03/31/2026
JOHNSON JENNIFER M	COMPRA	—	Not reported	03/28/2026	03/31/2026
Lynch Karen S	COMPRA	—	Not reported	03/28/2026	03/31/2026
Keith R. Alexandra	COMPRA	—	Not reported	03/28/2026	03/31/2026

Sobre la compañía

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Fuente - Link

Competidores

A ABT AMGN AZN DHR IQV ISRG MRK NVO NVS

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Why Thermo Fisher (TMO) Could Beat Earnings Estimates Again

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research

Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings

Thermo Fisher Scientific Inc. (NYSE:TMO) will release its third quarter earnings report before the opening bell on Wednesday, Oct. 21.

Benzinga

Two stocks poised to benefit from rotation out of AI

Investors looking beyond artificial intelligence (AI) should closely watch two healthcare names – Thermo Fisher Scientific (TMO) and Waters (WAT) – according to Josh Brown. In his latest report, the Ritholtz' chief executive highlighted laboratory equipment suppliers whose improving businesses are attracting buyers as tech stocks face pressure.

Invezz

TMO DCF Analysis: Intrinsic Value $421 vs Price $690

On October 19, 2026, we conducted a DCF analysis for Thermo Fisher Scientific Inc (TMO), a company that has shown impressive price performance over the past yea

GuruFocus

Banque Pictet & Cie SA Sells 6,618 Shares of Thermo Fisher Scientific Inc. $TMO

Banque Pictet and Cie SA cut its stake in Thermo Fisher Scientific Inc. (NYSE: TMO) by 26.1% during the quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,703 shares of the medical research company's stock after selling 6,618 shares during the

Defense World

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-04-23	5.25	5.44	0.19
2026-01-29	6.45	6.57	0.12
2025-10-22	5.5	5.79	0.29
2025-07-23	5.23	5.36	0.13
2025-04-23	5.1	5.15	0.05
2025-01-30	5.94	6.1	0.16
2024-10-23	5.25	5.28	0.03
2024-07-24	5.12	5.37	0.25
2024-04-24	4.71	5.11	0.4
2024-01-31	5.64	5.67	0.03
2023-10-25	5.61	5.69	0.08
2023-07-26	5.43	5.15	-0.28